Prospective, single-centre, feasibility study to evaluate the use of 18F-PSMA PET/CT in patients with biochemically active medullary thyroid cancer.
Recruiting
- Conditions
- Medullary thyroid cancer10043739thyroid cancer
- Registration Number
- NL-OMON51749
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all
of the following inclusion criteria:
- At least 18 years of age
- Histological or cytological proven MTC
- Biochemical evidence of disease activity (elevated/increasing calcitonin
and/or CEA)
- Clinical indication for an 18F-FDG PET/CT
- Able to follow instructions to participate in the study
- Able to give informed consent
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded
from participation in this study: - Patients with prostate cancer or renal cell
carcinoma - Pregnant patients - Recent neck surgery (<3 months ago)
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method